PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30203438-1	2019	AIMS: To evaluate the role of free fatty acid receptor 2 (FFAR2)/G-protein coupled receptor 43 in mediating the effects of the short chain fatty acids (SCFAs) sodium acetate (SA) and sodium propionate (SP) on islet function in vitro, and to identify the intracellular signalling pathways used in SCFA-induced potentiation of glucose-induced insulin secretion.	Sodium Acetate	159-173	free fatty acid receptor 2	Mus musculus	30-56	
32482686-10	2020	CONCLUSIONS: Manipulation of the microbiome by a high-fiber diet or supplementation with sodium acetate modified alloimmunity in a kidney transplant model, generating tolerance dependent on Tregs and GPR43.	Sodium Acetate	89-103	free fatty acid receptor 2	Mus musculus	200-205	
30203438-1	2019	AIMS: To evaluate the role of free fatty acid receptor 2 (FFAR2)/G-protein coupled receptor 43 in mediating the effects of the short chain fatty acids (SCFAs) sodium acetate (SA) and sodium propionate (SP) on islet function in vitro, and to identify the intracellular signalling pathways used in SCFA-induced potentiation of glucose-induced insulin secretion.	Sodium Acetate	159-173	free fatty acid receptor 2	Mus musculus	58-63	
30203438-1	2019	AIMS: To evaluate the role of free fatty acid receptor 2 (FFAR2)/G-protein coupled receptor 43 in mediating the effects of the short chain fatty acids (SCFAs) sodium acetate (SA) and sodium propionate (SP) on islet function in vitro, and to identify the intracellular signalling pathways used in SCFA-induced potentiation of glucose-induced insulin secretion.	Sodium Acetate	159-173	free fatty acid receptor 2	Mus musculus	65-94	
30203438-1	2019	AIMS: To evaluate the role of free fatty acid receptor 2 (FFAR2)/G-protein coupled receptor 43 in mediating the effects of the short chain fatty acids (SCFAs) sodium acetate (SA) and sodium propionate (SP) on islet function in vitro, and to identify the intracellular signalling pathways used in SCFA-induced potentiation of glucose-induced insulin secretion.	Sodium Acetate	175-177	free fatty acid receptor 2	Mus musculus	30-56	
30203438-1	2019	AIMS: To evaluate the role of free fatty acid receptor 2 (FFAR2)/G-protein coupled receptor 43 in mediating the effects of the short chain fatty acids (SCFAs) sodium acetate (SA) and sodium propionate (SP) on islet function in vitro, and to identify the intracellular signalling pathways used in SCFA-induced potentiation of glucose-induced insulin secretion.	Sodium Acetate	175-177	free fatty acid receptor 2	Mus musculus	58-63	
30203438-1	2019	AIMS: To evaluate the role of free fatty acid receptor 2 (FFAR2)/G-protein coupled receptor 43 in mediating the effects of the short chain fatty acids (SCFAs) sodium acetate (SA) and sodium propionate (SP) on islet function in vitro, and to identify the intracellular signalling pathways used in SCFA-induced potentiation of glucose-induced insulin secretion.	Sodium Acetate	175-177	free fatty acid receptor 2	Mus musculus	65-94	
30203438-6	2019	SA and SP reversibly potentiated insulin secretion from mouse islets in a FFAR2-dependent manner.	Sodium Acetate	0-2	free fatty acid receptor 2	Mus musculus	74-79	
30203438-8	2019	SA and SP protected human and mouse islets from apoptosis, and these pro-survival properties were dependent on islet expression of FFAR2.	Sodium Acetate	0-2	free fatty acid receptor 2	Mus musculus	131-136	
30203438-9	2019	CONCLUSION: Our results indicate that FFAR2 directly mediates both the stimulatory effects of SA and SP on insulin secretion and their protection against islet apoptosis.	Sodium Acetate	94-96	free fatty acid receptor 2	Mus musculus	38-43